Survival of patients after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis
| Main Authors: | , , , , , |
|---|---|
| Format: | Conference item |
| Published: |
2004
|
| _version_ | 1826301424972070912 |
|---|---|
| author | Isaacs, J Clarke, A Hazleman, B Hale, G Waldmann, H Symmons, D |
| author_facet | Isaacs, J Clarke, A Hazleman, B Hale, G Waldmann, H Symmons, D |
| author_sort | Isaacs, J |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-07T05:32:14Z |
| format | Conference item |
| id | oxford-uuid:e2a9a3e7-a047-4151-81dd-5e0df84b1463 |
| institution | University of Oxford |
| last_indexed | 2024-03-07T05:32:14Z |
| publishDate | 2004 |
| record_format | dspace |
| spelling | oxford-uuid:e2a9a3e7-a047-4151-81dd-5e0df84b14632022-03-27T10:03:06ZSurvival of patients after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritisConference itemhttp://purl.org/coar/resource_type/c_5794uuid:e2a9a3e7-a047-4151-81dd-5e0df84b1463Symplectic Elements at Oxford2004Isaacs, JClarke, AHazleman, BHale, GWaldmann, HSymmons, D |
| spellingShingle | Isaacs, J Clarke, A Hazleman, B Hale, G Waldmann, H Symmons, D Survival of patients after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis |
| title | Survival of patients after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis |
| title_full | Survival of patients after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis |
| title_fullStr | Survival of patients after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis |
| title_full_unstemmed | Survival of patients after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis |
| title_short | Survival of patients after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis |
| title_sort | survival of patients after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis |
| work_keys_str_mv | AT isaacsj survivalofpatientsafterlymphocytotoxicmonoclonalantibodytherapyforrheumatoidarthritis AT clarkea survivalofpatientsafterlymphocytotoxicmonoclonalantibodytherapyforrheumatoidarthritis AT hazlemanb survivalofpatientsafterlymphocytotoxicmonoclonalantibodytherapyforrheumatoidarthritis AT haleg survivalofpatientsafterlymphocytotoxicmonoclonalantibodytherapyforrheumatoidarthritis AT waldmannh survivalofpatientsafterlymphocytotoxicmonoclonalantibodytherapyforrheumatoidarthritis AT symmonsd survivalofpatientsafterlymphocytotoxicmonoclonalantibodytherapyforrheumatoidarthritis |